{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:36:04Z","timestamp":1759667764139,"version":"3.41.2"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00274","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T04:37:17Z","timestamp":1532407037000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Trastuzumab Emtansine for the Treatment of HER-2 Positive Carcinoma Ex-pleomorphic Adenoma Metastatic to the Brain: A Case Report"],"prefix":"10.3389","volume":"8","author":[{"given":"Ihab","family":"Hassanieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Hilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine A.","family":"Al Feghali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Khalifeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassem","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"B1","first-page":"279","article-title":"Malignant mixed tumors of the salivary glands: a review","author":"Gnepp","year":"1993","journal-title":"Pathol Annu."},{"key":"B2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/1097-0142(197702)39:2<388::AID-CNCR2820390204>3.0.CO;2-D","article-title":"Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases","volume":"39","author":"Spiro","year":"1977","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1002\/hed.24634","article-title":"Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature","volume":"39","author":"Thorpe","year":"2017","journal-title":"Head Neck"},{"key":"B4","first-page":"1483","article-title":"CNS metastases of carcinoma ex pleomorphic adenoma of the parotid gland","volume":"27","author":"Sheedy","year":"2006","journal-title":"Am J Neuroradiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00701-017-3080-9","article-title":"Brain metastasis of carcinoma ex pleomorphic adenoma of the parotid gland: case report and review of the literature","volume":"159","author":"Lau","year":"2017","journal-title":"Acta Neurochir. (Wien)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1053\/hupa.2001.25000","article-title":"Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases","volume":"32","author":"Lewis","year":"2001","journal-title":"Hum Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1111\/j.1365-2559.2012.04201.x","article-title":"HER-2\/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study","volume":"60","author":"Kazuki","year":"2012","journal-title":"Histopathology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1758-3284-2-12","article-title":"Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine","volume":"2","author":"Sharon","year":"2010","journal-title":"Head Neck Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000355219","article-title":"Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma","volume":"6","author":"Kadowaki","year":"2013","journal-title":"Case Rep Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ctrc.2016.03.005","article-title":"Activity of Trastuzumab-Emtansine (TDM1) in HER2-Positive Breast cancer brain metastases: a case series","volume":"7","author":"Keith","year":"2016","journal-title":"Cancer Treat Commun."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T04:37:18Z","timestamp":1532407038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":10,"alternative-id":["10.3389\/fonc.2018.00274"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00274","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"article-number":"274"}}